Galectin Therapeutics Inc. (GALT)

[biotech2010]

I'm not the bad guy in this story, it's GALT management. The one certainty, based on their history, is that they will use the ATM arrangement to raise money any time the stock shows some strength because Traber has an insatiable need to line his pockets. And that will significantly dilute the stock, period.

Just because you believe their technology is worth $500M doesn't make it so and obviously no major pharma does either or they would have a deal by now.

You can be a shareholder as long as you want with this mess of a management team, I was done as of a week ago, just as I posted earlier and am just holding some options as a hedge so I will come out OK if something completely unexpected occurs.

I spent over 8 years as a shareholder and it's been a profitable investment although it should have been a grand slam home run that Traber and his buffoonery turned into a death spiral unless the CX trial is a huge success.